Prevalence and Clinical Impact of Concomitant Mutations in Anaplastic Lymphoma Kinase Rearrangement Advanced Non-small-Cell Lung Cancer (Guangdong Association of Thoracic Oncology Study 1055)-Reference-Cited by-同舟云学术

Prevalence and Clinical Impact of Concomitant Mutations in Anaplastic Lymphoma Kinase Rearrangement Advanced Non-small-Cell Lung Cancer (Guangdong Association of Thoracic Oncology Study 1055)

Published:2020-08-21 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Li Meichen,Hou Xue,Zhou Chengzhi,Feng Weineng,Jiang Guanming,Long Hao,Yang Shuang,Chen Jing,Wang Na,Wang Kaicheng,Chen Likun

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference35 articles.

1. Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicine;Katayama;Clin Cancer Res.,2015

2. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer;Soda;Nature.,2007

3. EML4-ALK variants: biological and molecular properties, and the implications for patients;Sabir;Cancers.,2017

4. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer;Takeuchi;Clin Cancer Res.,2009

5. KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only;Togashi;PLoS ONE.,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib‐refractory ALK‐positive NSCLC from a phase II study;Cancer Communications;2024-02-29

2. The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review;Annals of Oncology;2023-12

3. Impact of non-canonical ALK fusion on the efficacy of targeted therapy in non-small cell lung cancer;Chinese Medical Journal;2023-11-29

4. Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients;Annals of Medicine;2023-03-10

5. Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study;Cancer Genetics;2023-01